Are there really biomarkers of vulnerable plaque?

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 151-153

  Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BIOLOGICAL MARKER; GELATINASE B; MYELOPEROXIDASE; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; EARLY DIAGNOSIS; HEART MUSCLE NECROSIS; HUMAN; INFLAMMATORY CELL; MEDICAL LITERATURE; NOTE; STABLE ANGINA PECTORIS; VULNERABLE POPULATION;

BIOLOGICAL MARKERS; HUMANS; PLAQUE, ATHEROSCLEROTIC;

EID: 84856074443     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.165811     Document Type: Note

References (14)

1. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30:1282-92.
2. Rittersma SZH, van der Wal AC, Koch KT, Piek JJ, Henriques JPS, Mulder KJ, et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005;111:1160-5. (Pubitemid 40365478)
3. Kubo T, Imanishi T, Kashiwagi M, Ikejima H, Tsujioka H, Kuroi A, et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol 2009;105:318-22.
4. Hong MK, Mintz GS, Lee CW, Park KM, Lee BK, Kim YH, et al. Plaque ruptures in stable angina pectoris compared with acute coronary syndrome. Int J Cardiol 2007;114:78-82. (Pubitemid 44791474)
5. Sato Y, Hatakeyama K, Marutsuka K, Asada Y. Incidence of asymptomatic coronary thrombosis and plaque disruption: comparison of non-cardiac and cardiac deaths among autopsy cases. Thromb Res 2009;124:19-23.
6. McCann CJ, Glover BM, Menown IBA, Moore MJ, McEneny J, Owens CG, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008;29:2843-50.
7. Möckel M, Danne O, Müller R, Vollert JO, Müller C, Lueders C, et al. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta 2008;393:103-9.
8. Apple FS, Pearce LA, Chung A, Ler R, Murakami MM. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2007;53:874-81. (Pubitemid 46744243)
9. McCann CJ, Glover BM, Menown IBA, Moore MJ, McEneny J, Owens CG, et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol 2009;103:22-8.
10. Brügger-Andersen T, Aarsetøy H, Grundt H, Staines H, Nilsen DWT. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thromb Res 2008;123:60-6.
11. Iversen K, Teisner A, Dalager S, Olsen KE, Floridon C, Teisner B. Pregnancy associated plasma protein-A (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque. Clin Biochem 2010;44:312-8.
12. Lund J, Wittfooth S, Qin QP, Ilva T, Porela P, Pulkki K, et al. Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome. Clin Chem 2010;56:1158-65.
13. Iversen KK, Teisner AS, Teisner B, Kliem A, Thanning P, Nielsen H, et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem 2009;42:828-34.
14. Elesber AA, Conover CA, Denktas AE, Lennon RJ, Holmes DR, Overgaard MT, et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 2006;27:1678-84. (Pubitemid 44025354)